With reference to R21/Matrix-M Vaccine, consider the following statements:1.It is a Malaria Vaccine.2.The vaccine contains R21 antigen developed by University of Oxford, specific to the malaria parasite, and Novavax’s Matrix-M, a saponin-based adjuvant that enhances the immune response, making it broader and more durable.3.The vaccine is administered orally, rather than by injection.How many of the above statements are correct?

Q. With reference to R21/Matrix-M Vaccine, consider the following statements:
1.It is a Malaria Vaccine.
2.The vaccine contains R21 antigen developed by University of Oxford, specific to the malaria parasite, and Novavax’s Matrix-M, a saponin-based adjuvant that enhances the immune response, making it broader and more durable.
3.The vaccine is administered orally, rather than by injection.
How many of the above statements are correct?

[A] Only one

[B] Only two

[C] All three

[D] None

Answer: B

Notes:

Explanation –

Statements 1 and 2 are correct. R21/Matrix-M Vaccine is a new vaccine recommended by the World Health Organization (WHO) for the prevention of malaria in children. The vaccine contains R21 antigen developed by University of Oxford, specific to the malaria parasite, and Novavax’s Matrix-M, a saponin-based adjuvant that enhances the immune response, making it broader and more durable.

Statement 3 is incorrect. The vaccine is not administered orally, but rather through intramuscular injection.

Source: ForumIAS

Post-Mains Strategy Session by Mr. Ayush Sinha | ForumIAS